A New Drug Can Extend The Life Of Some Men With Advanced Prostate Cancer

Although we are beginning, largely as a result ofadvanced prostate cancer.
education, to detect more cases of prostate cancerAmongst a small study group of men with advanced
in their early stages, unfortunately all too many casesprostate cancer the use of Pertuzumab was shown
are still not being detected until they are quiteto stabilize the disease for varying periods of time
advanced.and, overall, extended the 12 month survival rate of
Advanced prostate cancer refers to a cancer whichthe group as a whole to nearly 75%, which
has spread outside of the prostate gland itself and iscompared favorably to the expected survival rate
divided into stage 3 cancer, in which the disease haswithout treatment of less than 50%.
spread into the pelvic tissue surrounding the prostatePertuzumab is a form of monoclonal antibody which is
gland, and stage 4 cancer, in which the disease hasproduced in a laboratory and is designed to seek out
spread, or metastasized, into other areas of theand bind with specific cells. In the case of prostate
body, typically being carried by the lymphatic system.cancer Pertuzumab is designed to seek out a protein
Although not easy, stage 3 prostate cancer canknown as epidermal growth factor, which plays a
often be treated quite effectively and it is possible tosignificant role in the growth of prostate cancer cells.
cure prostate cancer in stage 3. Once the diseaseMonoclonal antibodies are not new and can be used
has reached stage 4 however it becomes veryalone or to carry drugs, toxins or radioactive material
difficult to cure and, while a cure is sometimesdirectly to the site of a tumor. Each antibody is
possible, treatment (typically the removal of thedesigned to seek out specific cells and a number of
testes, to starve the cancer of testosterone, andmonoclonal antibodies are already in use treating
chemotherapy) is generally aimed at managing thecancers, while others are in development or
condition by slowing the progression of the diseaseundergoing clinical trials.
and providing the patient with the best possibleThe use of this form of targeted therapy is evolving
quality of life.rapidly in the management of cancer patients in
To this end, recent clinical trials have been examininggeneral and it is hoped that with further development
the use of a drug called Pertuzumab and initial resultsthis will become a significant form of treatment for
suggest that this drug may well be effective inadvanced prostate cancer patients.
extending the life of many men suffering from